Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
NCT00233636 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2011-01-27
Summary
The aim of the study is to determine if Iressa added to radiotherapy is effective and safe in shrinking tumour dimensions.
Conditions
- Head and Neck Cancer
- Carcinoma, Squamous Cell
Interventions
- DRUG
-
Iressa (Gefitinib)
- PROCEDURE
-
Radiotherapy
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca Italy Medical Director, MD · AstraZeneca
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
Countries
- Italy
Study Locations
More Related Trials
-
Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
NCT00206219 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
NCT00195078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer
NCT00242762 ·Status: COMPLETED ·Phase: PHASE2
-
The IRESSA Novel Head and Neck Chemotherapy Evaluation Study
NCT00255476 ·Status: COMPLETED ·Phase: PHASE2
-
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
NCT00126555 ·Status: COMPLETED ·Phase: PHASE2
-
Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer
NCT00681967 ·Status: COMPLETED ·Phase: PHASE1
-
Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer
NCT00352105 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00024089 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma
NCT01185158 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
NCT00193284 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
NCT00519077 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer
NCT01185171 ·Status: COMPLETED ·Phase: PHASE2
-
Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas
NCT00169221 ·Status: TERMINATED ·Phase: PHASE2
-
Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
NCT00083057 ·Status: COMPLETED ·Phase: PHASE1
-
Gefitinib in Treating Patients With Cervical Cancer
NCT00049556 ·Status: COMPLETED ·Phase: PHASE2
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck
NCT00015964 ·Status: COMPLETED ·Phase: PHASE2
-
Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy
NCT06806683 ·Status: ACTIVE_NOT_RECRUITING
-
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
NCT02158234 ·Status: COMPLETED ·Phase: PHASE1
-
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NCT05992610 ·Status: RECRUITING ·Phase: NA
-
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
NCT05909904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00033449 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and Neck
NCT05291663 ·Status: UNKNOWN
-
Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours
NCT03238378 ·Status: RECRUITING ·Phase: NA
-
Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma
NCT01291095 ·Status: UNKNOWN ·Phase: PHASE2